Telephone Counseling and Numberless Scales to Overcome Barriers to Adolescent Weight Loss

NCT04241939 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-11-09

No results posted yet for this study

Summary

This study tests the feasibility and acceptability of a numberless behavioral digital scale (BDS) intervention combined with motivational interviewing (MI) to affect lifestyle changes to promote weight loss in adolescents who are obese. Half of the participants will receive this intervention, while the other half will use a digital scale along with the standard adolescent weight loss program.

Conditions

Interventions

BEHAVIORAL

Numberless BDS

Participants perform daily weighing using a numberless BDS with feedback from app (color codes, challenges), in conjunction with modified motivational interviewing (clinic visits and weekly telephone calls), and the standard adolescent weight loss program.

BEHAVIORAL

Digital Scale

Participants perform daily weighing using a digital scale (number readout), in conjunction with standard adolescent weight loss program

BEHAVIORAL

Modified Motivational Interviewing

Modified motivational interviewing (clinic visits and weekly telephone calls), and the standard adolescent weight loss program.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • The University of Texas Medical Branch, Galveston

    lead OTHER

Principal Investigators

  • Kanika Bowen-Jallow, MD, MMS · University of Texas

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-14
Primary Completion
2020-09-14
Completion
2020-09-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04241939 on ClinicalTrials.gov